Derek Finnegan Author’s Note: I’ve spent 14 years on the front lines of substance misuse—from liaison work in high-security settings to managing service pathways. I’ve seen the damage that dependency-forming medicines can do when they go off the rails. You can use the ‘Listen to this article’ audio player at the top of the page if you prefer to hear this breakdown, or use the Facebook share link below to pass this on to someone who needs to see it.
[Listen to this article] | [Share this on https://www.lbc.co.uk/article/britains-opioid-crisis-is-killing-thousands-and-were-still-handing-out-the-pills-5HjdWq4_2/ Facebook]
When the Care Quality Commission (CQC) published their landmark findings regarding the surge in opioid-related deaths, they didn’t mince their words. They labelled it a “preventable death issue” for people aged 15-49. In plain English? This isn’t a series of tragic accidents; it is a systemic failure in how we manage pain and dependency in primary care.
For years, the narrative around addiction has been stained by the “bad choices” myth—the idea that dependency is a character flaw. But when you look at the data—and I spend my life looking at the data—you see a different story. You see a story of people who went to their GP for back pain or a chronic injury, were prescribed something to help, and became tethered to a drug that their body now chemically requires.
The CQC 2017 Report: A Watershed Moment
The CQC 2017 report on opioid safety in the UK served as a massive wake-up call for the NHS. Before this, the conversation was heavily focused on illicit substances. The report shifted the lens to “prescribed medicines.”
The CQC highlighted that while opioids like codeine, tramadol, and oxycodone are vital for acute pain (like recovery from major surgery), their long-term use for chronic, non-cancer pain is a different beast entirely. The evidence for their effectiveness drops off a cliff after a few months, but the risk of dependency and respiratory depression—the mechanism that actually causes overdose deaths—remains high.
High Volume Prescribing: Why the Numbers Keep Climbing
If you look at the data from the NHS Business Services Authority (NHSBSA), you see the scale of the “volume” problem. We are talking about millions of prescriptions issued every year. In my time as a service manager, I often sat in meetings where we discussed the “prescribing culture.”
It’s important to clarify the jargon: when we talk about “primary care,” we mean your local GP surgery. This is where the vast majority of these medicines are first handed out. The issue isn’t that doctors are being “bad”; it’s that we haven’t provided enough non-medical alternatives for pain management. If you’re a GP with a seven-minute appointment slot and a patient in obvious distress, a prescription pad is a quick—albeit often dangerous—solution. How to Find the Best Custom Home Builders Adelaide
The Cost Burden to the NHS
It’s not just the human cost; there is a massive financial burden. While it’s tempting to look only at the cost of the tablets, the real cost is the “downstream” expenditure: How Modular Compliance Systems Cut Regulatory Expense and Speed Up Platform Valuations
- Emergency Admissions: Opioid overdoses and complications requiring A&E care.
- Treatment Services: The stretched substance misuse services tasked with helping people taper off these drugs.
- Loss of Productivity: The impact on the working-age population (15-49).
Why 15-49? The “Preventable” Reality
Why did the CQC specifically highlight the 15-49 age bracket? Because this group is at the highest risk of poly-pharmacy—the practice of taking multiple medications at once. If you are taking an opioid for pain, a benzodiazepine for anxiety, and perhaps a sedative to sleep, your risk of a fatal respiratory depression increases exponentially.
We often hear pundits on stations like LBC debating “drug deaths,” but they almost always focus on street heroin. They rarely talk about the patient who is taking exactly what their doctor told them to take, but who is now in the grip of a physiological dependency that could kill them if they mix their meds with a glass of wine or an over-the-counter antihistamine.
The Myth of the “Miracle Cure”
I have to be clear here: I am skeptical of anyone claiming there is a simple “fix” for this. There is no miracle pill to undo the opioid crisis. The solution is boring, slow, and expensive. It involves:
What to ask your GP
If you or a loved one are currently on long-term opioid medication for chronic pain, do not panic and do not stop taking them abruptly—that can be dangerous. Instead, book a medication review. Here is what you should ask:
- “What is the long-term plan for this medication, and at what point will we look to reduce or stop it?”
- “Are there alternative, non-opioid treatments (like physiotherapy or psychological pain management) that I haven’t tried yet?”
- “What are the signs of dependency I should be looking out for?”
- “If I feel like my body is getting used to this dose, how should I report that to you?”
- “Can you review my other medications to ensure there are no dangerous interactions?”
The Path Forward
The CQC’s warning was not an attack on the NHS; it was a roadmap for change. We need to stop viewing addiction as a moral failing and start viewing it as a medical complication of long-term pain management. The NHS is capable of pivoting, but it requires us, the patients, to ask the right questions and demand evidence-based pain management rather than a quick-fix prescription.
We have the data, we have the guidance, and we have the clinicians who want to do better. The “preventable” in “preventable deaths” is the most important word in that CQC report. It means the power to change these outcomes is currently in our hands.
Disclaimer: I am a former NHS mental health nurse, not your doctor. This blog is for information purposes and does not replace medical advice. Always consult your GP before making changes to prescribed medication.
Home Design for Wellness: The Perfect Medicine Cabinet Setup
